AccentedTouch

“Rheumatoid arthritis (RA) is an inflammatory, polyarticular joint disease. A number of cellular responses are involved in the pathogenesis of rheumatoid arthritis, including activation of inflammatory cells and cytokine expression.” http://7thspace.com/headlines/392245/tyrosine_kinases_in_rheumatoid_arthritis.html

Cellular response that was implicated in the process depends on the signalling pathways specifically that are activated which include protein tyrosine pathway, janus kinases /signal transducers and activators transcription conduit, spleen tyrosine kinase signaling, and the nuclear factor kappa-light-chain-enhancer of activated B cells pathway.

A lot of drugs are in advance to mark tyrosine kinases for the treatment of RA. According to the number of newly published studies, the manuscript reviews the position of tyrosine kinases in the pathogenesis of RA and the potential role of kinase inhibitors as novel therapeutic strategies of RA.

On regular basis, by practicing tai chi it may significantly improve the symptoms of rheumatoid arthritis. There were some studies that show the good effect of tai chi for the symptoms of osteoarthritis that includes joint pain, stiffness and weakness. On the new medical study, it shows that the benefits of tai chi extend beyond simply reducing the symptoms.

“Rheumatoid arthritis is an autoimmune disease characterized by significant joint pain, fatigue and weakness. Over time the destruction of the joints can becom severe as to cause significant deformity. Although most patients with rheumatoid arthritis experience primarily joint pain, other organs in the body can be affected. Rheumatoid arthritis is most common in people between the ages of 40 and 50 years old and affects about 1 percent of the population.” http://www.dailyherald.com/article/20110822/entlife/708229987/

Women are usually affected more often than men and the most common destruction is on the joints and tendons. There are figures of medical therapies that can measure the development of rheumatoid arthritis. These comprise anti-inflammatory medications, steroids, powerful disease modifying medications like methotrexate and biologic agents specially marking the immune system.

On the other hand, the side effects may limit their use. Luckily, physical therapies are helpful for rheumatoid arthritis and decrease the need for medication. There is healthy data to point to that maintaining physical activity can get better the long-term results of patients with rheumatoid arthritis. Long-term observance with exercise programs is a dilemma, but with tai chi exercises compliance is better.

“A recent medical study published in the medical journal BMC Musculoskeletal Disorders re-examined the use of tai chi exercises in patients with rheumatoid arthritis. The study was different because not only did they look at the physical benefits of tai chi, but also they explored why with rheumatoid arthritis people practiced Tai chi. This is important because compliance with any physical therapy program, over time, is essential with rheumatoid arthritis patients.” http://www.dailyherald.com/article/20110822/entlife/708229987/

They found out that there was the usual development in physical function, but that patients furthermore felt better, mentally, following practicing tai chi. Stress levels were lesser, energy levels were higher and overall mental outlook was brighter. Patients sustained to practice tai chi because they purely felt better.

According to Patrick B. Massey, M.D., Ph.D, medical director for complementary and alternative medicine for the Alexian Brothers Hospital Network, he strongly agree with the result of the study. In his experience, martial art based exercises not only advance the physical condition, but in his cases have constructive impact on the mental and emotional state that merely feels good.

In the study, researchers found out that a defective gene can contribute to the start of rheumatoid arthritis that affects 1 percent of the world’s population. Up to now, the mechanism of the disease is still unclear. The researchers from VIB (Flanders Institute for Biotechnology) and Ghent University in a study in print in the journal Nature Genetics, verified that a cell-specific defect in the face of the A20 gene (TNFAIP3) can add to the A20 gene as a probable target for the subsequently generation of new drugs.

Protein A20 is an intracellular negative regulator of the NF-kB transcription factor that is a key role in the creation of the inflammatory response. Extreme look of NF-kB can direct to greatly inflammatory disease.

“Rheumatoid Arthritis (RA) is a form of arthritis that causes pain, swelling, stiffness and loss of function in joints. The disease can last for a short time, or symptoms might come and go. The severe form can last a lifetime. An estimated 1.293 million adults aged 18 and older (0.6%) has RA in the US.” http://www.medicaldaily.com/news/20110820/7051/rheumatoid-arthritis-arthritis-gene-a20-defect-cell.htm

The one who investigated the molecular mechanism that works to control NF-kB activation is Rudi Beyaert and found out that A20 plays a key role. Other studies recommended that A20 could contribute to some autoimmune disease that includes rheumatoid arthritis.

Researchers heritably developed mice with myeloid cells unable of producing A20. They set up that these mice had eminent levels of pro-inflammatory cytokines in their blood and joints, and impulsively developed RA with cruel inflammation and osteoporosis.

Study verifies the vital role of A20 in domineering inflammatory reaction and illustrate that fault in a20 in myeloid cells can give rise to RA.

According to the new study of rheumatoid arthritis patients, they have found out that those individuals have increase risk of dying from heart disease and also other cardiovascular events and that the risk can be decrease if there is right precaution.

On the study, they included about 400 patients that were monitored for five years from their time of diagnosis. The researchers have monitored their disease progressions, treatment programs and also the traditional risk factors linked with heart disease like weight, level of cholestero0l, blood pressure, diabetes and smoking.

USNews says that in treating RA inflammation together with disease modifying anti-rheumatic drugs (DMARDs) and the risk factors for the heart disease reduce the risk.

“Researchers found that after five years 97 percent of patients had been treated with DMARDs which are used to reduce inflammation, while they made lifestyle changes to avoid cardiovascular disease risk. DMARDs users were shown to have a decreased risk of death, while patients given cox 2 inhibitors seems to see an increase in risk.” http://www.inquisitr.com/135160/rheumatoid-arthritis-inflammation-increases-chance-of-heart-disease-related-death-study/

Dr. Wallberg-Jonsson from University Hospital, Umea, in Sweden said that the inflammation that was associated with RA increases the risk of heart diseases and also other cardiovascular events. But, it is possible to decrease the risk in two-prolonged attack by treating the inflammation as well as the traditional risk factors of heart disease. People with any type of inflammation are recommended to have their heart monitored regularly and should take steps to stop relieve that inflammation.

“London, August 15 (ANI): A team of scientists has found significant new clues to the development of rheumatoid arthritis(RA) and other autoimmune disorders including type 1 diabetes, lupus and Graves disease.” http://www.newstrackindia.com/newsdetails/235486

Dr. Katherine Siminovitch and her team using the advanced genomics technologies have identified the exact ways by which modification in the gene PTPN22 increases the risk for RA and in other autoimmune disorders.

Mouse genetic models have been generated in order to show how the PTPNN22 gene mutation damages the function of immune cells and then validating their function in humans. They take their discovery from laboratory bench up to the clinic.

The result of the study shows a more accurate knowledge and understanding on how autoimmune conditions develop and on how the new diagnostic test and targeted therapies can be made for symptom control as well as potential cure.

According to the lead author Dr. Siminovitch, senior investigator, the findings particularly is an exciting one because it sets a new model for studying arthritis and also other autoimmune disorders.

She added that the study is the first one in which they have traced the steps that link a specific genetic lesion to the development of a common, complex autoimmune condition.